SAN DIEGO, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Louis Villalba has been named Chief Business Officer (CBO), effective immediately. Mr. Villalba comes to Evofem with years of experience in pharmaceutical and medical technology sales in both the US and global markets.
In his role as CBO, Mr. Villalba will provide organizational leadership, manage strategic partnerships and lead Evofem, Inc.'s portfolio development. He will report directly to Saundra Pelletier, CEO.
"Lou's extensive and varied experience, along with his work in the field of women's health products, will make him a valuable member of Evofem, Inc.," said Pelletier. "We are excited to have him as part of our leadership team."
Mr. Villalba most recently served as Vice President of Sales for Auxogyn, a medical device company that specializes in IVF products. Prior to Auxogyn, he served as General Manager of Europe for Conceptus and was part of the team that completed the $1.1 billion sale of the company to Bayer AG in 2013. Prior to his tenure with Conceptus, Mr. Villalba held various Marketing, Sales Management, and Corporate Development positions at VIVUS, Inc.
"I am honored and excited to continue to work in the important field of global women's health," said Villalba. "I look forward to working with the entire Evofem team."
Mr. Villalba earned a BA in Business Management at Menlo College.
About Evofem, Inc.
Evofem, Inc. is a privately held biotechnology company that discovers, develops and commercializes prescription and over-the-counter products in the areas of feminine care, contraception, and the prevention of sexually transmitted infections. Evofem, Inc. is committed to delivering effective, woman-controlled, rapidly reversible forms of contraception to women globally.